Press release

Transcat Reports Operating Income of $1.0 Million from Service Segment Revenue and Margin Growth for Fiscal 2021 First Quarter

0
Sponsored by Businesswire

Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, today reported financial results for its first quarter ended June 27, 2020 (the “first quarter”) of fiscal year 2021, which ends March 27, 2021 (“fiscal 2021”). Results include the previously-reported acquisition of TTE Laboratories, Inc. (which we refer to as “pipettes.com”) effective February 21, 2020.

“We are extremely proud of our organization and the invaluable contributions our people made during these difficult times. Our staff at our 42 labs have worked tirelessly to remain open and meet the demands of our customers, particularly those in the Life Sciences sector,” commented Lee D. Rudow, President and CEO. “Our first quarter results are a testament to the value and effective execution of our strategy. Our commitment to technology and process improvements positively impacted our results as increased productivity drove higher Service segment gross margins. We believe the improvements are sustainable and we expect to see additional traction and margin enhancement as we move forward.”

Mr. Rudow added, “The 20% decline in Distribution sales was expected and was the direct result of the impact of the COVID-19 pandemic on customer demand throughout the quarter. Nonetheless, the contribution from the Service business combined with company-wide cost saving measures, which we implemented early on in the pandemic to protect the financial strength and liquidity of the Company, and which continued in our first quarter, resulted in operating income of $1.0 million for the first quarter. This exceeded our expectation of operating income being in the break-even range that we had forecast in May 2020 when we released fiscal year-end results.”

First Quarter Fiscal 2021 Review

(Results are compared with the first quarter of the fiscal year ended March 28, 2020 (“fiscal 2020”))

($ in thousands)

 

 

 

 

Change

FY21 Q1

 

FY20 Q1

 

$’s

 

%

Service Revenue

$

22,967

 

$

22,398

$

569

 

2.5%

Distribution Sales

 

15,937

 

 

19,997

 

(4,060)

 

(20.3%)

Revenue

$

38,904

 

$

42,395

$

(3,491)

 

(8.2%)

Gross Profit

$

9,409

 

$

10,052

$

(643)

 

(6.4%)

Gross Margin

 

24.2%

 

 

23.7%

 

 

 

 

 

 

 

 

 

Operating Income

$

964

 

$

1,958

$

(994)

 

(50.8%)

Operating Margin

 

2.5%

 

 

4.6%

 

 

 

Net Income

$

798

 

$

1,718

$

(920)

 

(53.6%)

Net Margin

 

2.1%

 

 

4.1%

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA*

$

3,488

 

$

3,942

$

(454)

 

(11.5%)

Adjusted EBITDA* Margin

 

9.0%

 

 

9.3%

 

 

 

*See Note 1 on page 4 for a description of this non-GAAP financial measure and page 9 for the Adjusted EBITDA Reconciliation table.

The economic downturn from the COVID-19 pandemic impacted customer demand, especially for the Distribution segment, and resulted in consolidated revenue declining 8.2% in the first quarter. Consolidated gross profit was $9.4 million, a decrease of $0.6 million, or 6.4%, while gross margin expanded 50 basis points due to productivity improvements in the Service segment and various cost reduction efforts. Operating expenses increased $0.4 million, or 4.3%, and included incremental expenses related to pipettes.com and approximately $0.4 million of severance expense as technology advancements allowed the Company to lower its ongoing operating expenses but resulted in certain charges in the quarter. Net income per diluted share decreased to $0.11 from $0.23.

Service segment shows revenue growth for 45th straight quarter

Represents the accredited calibration, repair, inspection and laboratory instrument services business (59% of total revenue for the first quarter of fiscal 2021).

($ in thousands)

 

 

 

 

Change

FY21 Q1

 

FY20 Q1

 

$’s

 

%

 

 

 

 

 

 

 

 

Service Segment Revenue

$

22,967

 

$

22,398

 

$

569

 

2.5%

Gross Profit

$

6,069

 

$

5,372

 

$

697

 

13.0%

Gross Margin

 

26.4%

 

 

24.0%

 

 

 

 

 

 

 

 

 

 

 

 

Operating Income

$

1,129

 

$

738

 

$

391

 

53.0%

Operating Margin

 

4.9%

 

 

3.3%

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA*

$

2,863

 

$

2,147

 

$

716

 

33.4%

Adjusted EBITDA* Margin

 

12.5%

 

 

9.6%

 

 

 

 

Service revenue grew as new business and increased demand from the Life Sciences market combined with $1.1 million of incremental revenue from pipettes.com more than offset softness from other markets. On a trailing twelve-month basis, Service segment revenue was $93.6 million, up 7.4% when compared with the trailing twelve-month period ending with the prior-fiscal year first quarter.

Ongoing productivity improvements along with prudent cost reduction initiatives resulted in an increase of Service gross margin by 240 basis points.

Distribution segment revenue and margins impacted by COVID-19 pandemic

Represents the sale and rental of new and used professional grade handheld test, measurement and control instrumentation (41% of total revenue for the first quarter of fiscal 2021).

($ in thousands)

 

 

 

 

Change

FY21 Q1

 

FY20 Q1

 

$’s

 

%

Distribution Segment Sales

$

15,937

 

$

19,997

 

$

(4,060)

 

(20.3%)

Gross Profit

$

3,340

 

$

4,680

 

$

(1,340)

 

(28.6%)

Gross Margin

 

21.0%

 

 

23.4%

 

 

 

 

 

 

 

 

 

 

Operating (Loss) Income

$

(165)

 

$

1,220

 

$

(1,385)

 

(113.5%)

Operating Margin

 

(1.0%)

 

 

6.1%

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA*

$

625

 

$

1,795

 

$

(1,170)

 

(65.2%)

Adjusted EBITDA* Margin

 

3.9%

 

 

9.0%

 

 

 

 

*See Note 1 on page 4 for a description of this non-GAAP financial measure and page 9 for the Adjusted EBITDA Reconciliation table.

As expected, Distribution sales were impacted by the COVID-19 pandemic, with reduced demand from oil and gas related businesses and most other industrial manufacturing sectors. Rental revenue was $1.0 million in the quarter, down 18.1%. Distribution gross margin was impacted by lower volume, less demand from core product sales and reduced co-operative advertising and rebate programs as vendors reduced these programs to lower their own costs.

Solid Balance Sheet and Sufficient Liquidity

Net cash provided by operations increased to $4.0 million from $0.9 million in the prior-fiscal year first quarter and was used to fund $1.3 million of capital expenditures and debt repayment. Capital investments were focused on technology and Service segment capabilities, and for rental pool assets.

At the end of the first quarter, Transcat had $27.3 million in net working capital and $23.6 million available for borrowing under its secured revolving credit facility. On May 18, 2020, the Company amended its revolving credit facility to include a $10.0 million increase in borrowing capacity and provide financial covenant modifications, among other customary provisions. Total debt at the end of the quarter was down $1.8 million to $28.5 million compared with the balance at fiscal 2020 year-end. The Company’s leverage ratio, as defined in its credit agreement, was down to 1.50 at quarter end, compared with 1.53 at fiscal 2020 year-end.

Outlook

Mr. Rudow concluded, “Encouragingly, Service demand strengthened through June and into July, although we are cautious with our outlook given the trend in new cases of COVID-19 across North America. For the second quarter of fiscal 2021, we expect Service revenue to grow modestly versus last fiscal year’s second quarter, and anticipate improved gross margin. Distribution is likely to remain relatively unchanged sequentially. We expect operating income to grow sequentially from the first quarter of fiscal 2021 by approximately $1 million and to be in the range of $2 million for our second quarter of fiscal 2021. Overall, we believe we are managing and navigating this pandemic well, while continuing to advance our technology in support of our growth and profitability strategy.”

Transcat revised its fiscal year 2021 income tax rate to range between 20% and 21% from the previous estimated range of 24% to 25%. This estimate includes Federal, various state, and Canadian income taxes and reflects the discrete tax benefit associated with share-based payment and stock option activity.

The Company anticipates total capital expenditures to be approximately $5.0 million to $5.5 million in fiscal 2021, with the majority of the capital expenditures planned for technology, growth-oriented opportunities within both of its operating segments, and rental pool assets. Maintenance and existing asset replacements are expected to be consistent with fiscal 2020 at approximately $1.0 million to $1.5 million.

Webcast and Conference Call

Transcat will host a conference call and webcast on Wednesday, July 22, 2020 at 11:00 a.m. ET. Management will review the financial and operating results for the first quarter, as well as the Company’s strategy and outlook. A question and answer session will follow the formal discussion. The review will be accompanied by a slide presentation, which will be available at www.transcat.com/investor-relations. The conference call can be accessed by calling (201) 689-8471. Alternatively, the webcast can be monitored at www.transcat.com/investor-relations.

A telephonic replay will be available from 2:00 p.m. ET on the day of the call through Wednesday, July 29, 2020. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13705865, or access the webcast replay at www.transcat.com/investor-relations, where a transcript will be posted once available.

NOTE 1 – Non-GAAP Financial Measures

In addition to reporting net income, a U.S. generally accepted accounting principle (“GAAP”) measure, we present Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, non-cash stock compensation expense, restructuring expense, and non-cash loss on sale of building), which is a non-GAAP measure. The Company’s management believes Adjusted EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the performance of its core operations from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, and stock-based compensation expense, which is not always commensurate with the reporting period in which it is included. As such, the Company uses Adjusted EBITDA as a measure of performance when evaluating its business segments and as a basis for planning and forecasting. Adjusted EBITDA is not a measure of financial performance under GAAP and is not calculated through the application of GAAP. As such, it should not be considered as a substitute for the GAAP measure of net income and, therefore, should not be used in isolation of, but in conjunction with, the GAAP measure. Adjusted EBITDA, as presented, may produce results that vary from the GAAP measure and may not be comparable to a similarly defined non-GAAP measure used by other companies. See the attached Adjusted EBITDA Reconciliation table below.

ABOUT TRANSCAT

Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device and other FDA-regulated businesses; as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 22 Calibration Service Centers strategically located across the United States, Puerto Rico and Canada, and services at 20 imbedded customer-site locations. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.

Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise and integrity create a unique and compelling value proposition for its customers.

Transcat’s strategy is to leverage the complementary nature of its two operating segments, its comprehensive service capabilities, strong brand, enhanced e-commerce capabilities and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model.

More information about Transcat can be found at: Transcat.com.

Safe Harbor Statement

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not statements of historical fact and thus are subject to risks, uncertainties and assumptions. Forward-looking statements are identified by words such as “expects,” “estimates,” “projects,” “anticipates,” “believes,” “could,” “plans,” “aims” and other similar words. All statements addressing operating performance, events or developments that Transcat, Inc. expects or anticipates will occur in the future, including but not limited to statements relating to anticipated revenue, profit margins, the Company’s response to the coronavirus (COVID-19) pandemic, the commercialization of software projects, sales operations, capital expenditures, cash flows, operating income, growth strategy, segment growth, potential acquisitions, integration of acquired businesses, market position, customer preferences, outlook and changes in market conditions in the industries in which Transcat operates are forward-looking statements. Forward-looking statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties include those more fully described in Transcat’s Annual Report and Quarterly Reports filed with the Securities and Exchange Commission, including under the heading entitled “Risk Factors.” Should one or more of these risks or uncertainties materialize, or should any of the Company’s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on the Company’s forward-looking statements, which speak only as of the date they are made. Except as required by law, the Company disclaims any obligation to update, correct or publicly announce any revisions to any of the forward-looking statements contained in this news release, whether as the result of new information, future events or otherwise.

FINANCIAL TABLES FOLLOW.

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

(Unaudited)

First Quarter Ended

June 27,

 

June 29,

2020

 

2019

Service Revenue

$

22,967

 

$

22,398

 

Distribution Sales

 

15,937

 

 

19,997

 

Total Revenue

 

38,904

 

 

42,395

 

 

Cost of Service Revenue

 

16,898

 

 

17,026

 

Cost of Distribution Sales

 

12,597

 

 

15,317

 

Total Cost of Revenue

 

29,495

 

 

32,343

 

 

Gross Profit

 

9,409

 

 

10,052

 

 

Selling, Marketing and Warehouse Expenses

 

4,074

 

 

4,472

 

General and Administrative Expenses

 

4,371

 

 

3,622

 

Total Operating Expenses

 

8,445

 

 

8,094

 

 

Operating Income

 

964

 

 

1,958

 

 

Interest and Other Expense, net

 

243

 

 

285

 

 

Income Before Income Taxes

 

721

 

 

1,673

 

Benefit from Income Taxes

 

(77

)

 

(45

)

 

Net Income

$

798

 

$

1,718

 

 

Basic Earnings Per Share

$

0.11

 

$

0.24

 

Average Shares Outstanding

 

7,394

 

 

7,257

 

 

Diluted Earnings Per Share

$

0.11

 

$

0.23

 

Average Shares Outstanding

 

7,514

 

 

7,491

 

TRANSCAT, INC.

CONSOLIDATED BALANCE SHEETS

(In Thousands, Except Share and Per Share Amounts)

 

(Unaudited)

 

(Audited)

June 27,

 

March 28,

2020

 

2020

ASSETS

Current Assets:

Cash

$

366

 

$

499

 

Accounts Receivable, less allowance for doubtful accounts of $730 and $480 as of June 27, 2020 and March 28, 2020, respectively

 

27,849

 

 

30,952

 

Other Receivables

 

894

 

 

1,132

 

Inventory, net

 

14,194

 

 

14,180

 

Prepaid Expenses and Other Current Assets

 

1,942

 

 

1,697

 

Total Current Assets

 

45,245

 

 

48,460

 

Property and Equipment, net

 

20,871

 

 

20,833

 

Goodwill

 

41,681

 

 

41,540

 

Intangible Assets, net

 

7,349

 

 

7,977

 

Right To Use Asset, net

 

8,284

 

 

8,593

 

Other Assets

 

733

 

 

719

 

Total Assets

$

124,163

 

$

128,122

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

Current Liabilities:

Accounts Payable

$

9,326

 

$

11,947

 

Accrued Compensation and Other Liabilities

 

6,588

 

 

6,907

 

Income Taxes Payable

 

 

 

86

 

Current Portion of Long-Term Debt

 

2,003

 

 

1,982

 

Total Current Liabilities

 

17,917

 

 

20,922

 

Long-Term Debt

 

26,524

 

 

28,362

 

Deferred Tax Liabilities

 

3,049

 

 

3,025

 

Lease Liabilities

 

6,535

 

 

6,832

 

Other Liabilities

 

2,682

 

 

1,894

 

Total Liabilities

 

56,707

 

 

61,035

 

 

Shareholders’ Equity:

Common Stock, par value $0.50 per share, 30,000,000 shares authorized; 7,411,117 and 7,381,180 shares issued and outstanding as of June 27, 2020 and March 28, 2020, respectively

 

3,706

 

 

3,691

 

Capital in Excess of Par Value

 

18,006

 

 

17,929

 

Accumulated Other Comprehensive Loss

 

(847

)

 

(1,010

)

Retained Earnings

 

46,591

 

 

46,477

 

Total Shareholders’ Equity

 

67,456

 

 

67,087

 

Total Liabilities and Shareholders’ Equity

$

124,163

 

$

128,122

TRANSCAT, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

For the First Quarter Ended

June 27,

 

June 29,

2020

 

2019

Cash Flows from Operating Activities:

Net Income

$

798

 

$

1,718

 

Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities:
(Gain) Loss on Sale of Property and Equipment

 

(1

)

 

238

 

Deferred Income Taxes

 

24

 

 

12

 

Depreciation and Amortization

 

1,872

 

 

1,622

 

Provision for Accounts Receivable and Inventory Reserves

 

561

 

 

102

 

Stock-Based Compensation Expense

 

312

 

 

203

 

Changes in Assets and Liabilities:
Accounts Receivable and Other Receivables

 

2,948

 

 

562

 

Inventory

 

5

 

 

(1,497

)

Prepaid Expenses and Other Assets

 

(251

)

 

(278

)

Accounts Payable

 

(2,621

)

 

(1,385

)

Accrued Compensation and Other Liabilities

 

494

 

 

(314

)

Income Taxes Payable

 

(99

)

 

(109

)

Net Cash Provided by Operating Activities

 

4,042

 

 

874

 

 

Cash Flows from Investing Activities:

Purchase of Property and Equipment

 

(1,261

)

 

(1,446

)

Proceeds from Sale of Property and Equipment

 

 

 

184

 

Net Cash Used in Investing Activities

 

(1,261

)

 

(1,262

)

 

Cash Flows from Financing Activities:

(Repayment of) Proceeds from Revolving Credit Facility, net

 

(1,330

)

 

1,823

 

Repayments of Term Loan

 

(487

)

 

(467

)

Issuance of Common Stock

 

383

 

 

369

 

Repurchase of Common Stock

 

(1,287

)

 

(1,346

)

Net Cash (Used in)/ Provided by Financing Activities

 

(2,721

)

 

379

 

 

Effect of Exchange Rate Changes on Cash

 

(193

)

 

(158

)

 

Net Decrease in Cash

 

(133

)

 

(167

)

Cash at Beginning of Period

 

499

 

 

788

 

Cash at End of Period

$

366

 

$

621

 

TRANSCAT, INC.

Adjusted EBITDA Reconciliation Table

(In thousands)

(Unaudited)

 

Fiscal 2021

Q1

 

Q2

 

Q3

 

Q4

 

YTD

Net Income

$

798

 

$

798

 

+ Interest Expense

 

224

 

 

224

 

+ Other Expense / (Income)

 

19

 

 

19

 

+ Tax Provision

 

(77

)

 

 

 

 

(77

)

Operating Income

$

964

 

 

 

 

$

964

 

+ Depreciation & Amortization

 

1,871

 

 

 

 

 

1,871

 

+ Restructuring Expense

 

360

 

 

 

 

 

360

 

+ Other (Expense) / Income

 

(19

)

 

(19

)

+ Noncash Stock Compensation

 

312

 

 

 

 

 

312

 

Adjusted EBITDA

$

3,488

 

 

 

 

$

3,488

 

 

Segment Breakdown

 

Service Operating Income

$

1,129

 

$

1,129

 

+ Depreciation & Amortization

 

1,394

 

 

1,394

 

+ Restructuring Expense

 

193

 

 

 

 

 

193

 

+ Other (Expense) / Income

 

(15

)

 

(15

)

+ Noncash Stock Compensation

 

162

 

 

 

 

 

162

 

Service Adjusted EBITDA

$

2,863

 

 

 

 

$

2,863

 

 

Distribution Operating Income

$

(165

)

$

(165

)

+ Depreciation & Amortization

 

477

 

 

477

 

+ Restructuring Expense

 

167

 

 

 

 

 

167

 

+ Other (Expense) / Income

 

(4

)

 

(4

)

+ Noncash Stock Compensation

 

150

 

 

 

 

 

150

 

Distribution Adjusted EBITDA

$

625

 

 

 

 

$

625

 

 

Fiscal 2020

Q1

 

Q2

 

Q3

 

Q4

 

YTD

Net Income

$

1,718

 

$

2,379

 

$

1,477

 

$

2,493

 

$

8,067

 

+ Interest Expense

 

244

 

 

243

 

 

216

 

 

231

 

 

934

 

+ Other Expense / (Income)

 

41

 

 

54

 

 

(22

)

 

113

 

 

186

 

+ Tax Provision

 

(45

)

 

383

 

 

420

 

 

905

 

 

1,663

 

Operating Income

$

1,958

 

$

3,059

 

$

2,091

 

$

3,742

 

$

10,850

 

+ Depreciation & Amortization

 

1,622

 

 

1,681

 

 

1,648

 

 

1,707

 

 

6,658

 

+ Other (Expense) / Income

 

159

 

 

(54

)

 

22

 

 

(112

)

 

15

 

+ Noncash Stock Compensation

 

203

 

 

102

 

 

305

 

 

274

 

 

884

 

Adjusted EBITDA

$

3,942

 

$

4,788

 

$

4,066

 

$

5,611

 

$

18,407

 

 

Segment Breakdown

 

Service Operating Income

$

738

 

$

1,837

 

$

488

 

$

2,609

 

$

5,672

 

+ Depreciation & Amortization

 

1,220

 

 

1,246

 

 

1,206

 

 

1,257

 

 

4,929

 

+ Other (Expense) / Income

 

77

 

 

(38

)

 

13

 

 

(72

)

 

(20

)

+ Noncash Stock Compensation

 

112

 

 

56

 

 

159

 

 

143

 

 

470

 

Service Adjusted EBITDA

$

2,147

 

$

3,101

 

$

1,866

 

$

3,937

 

$

11,051

 

 

Distribution Operating Income

$

1,220

 

$

1,222

 

$

1,603

 

$

1,133

 

$

5,178

 

+ Depreciation & Amortization

 

401

 

 

436

 

 

442

 

 

450

 

 

1,729

 

+ Other (Expense) / Income

 

83

 

 

(17

)

 

9

 

 

(40

)

 

35

 

+ Noncash Stock Compensation

 

91

 

 

46

 

 

146

 

 

131

 

 

414

 

Distribution Adjusted EBITDA

$

1,795

 

 

$

1,687

 

 

$

2,200

 

 

$

1,674

 

 

$

7,356

 

TRANSCAT, INC.

Additional Information – Business Segment Data

(Dollars in thousands)

(Unaudited)

 

 

 

 

 

Change

SERVICE

FY 2021 Q1

 

FY 2020 Q1

 

$’s

 

%

 

 

 

 

 

 

 

 

Service Revenue

$

22,967

 

$

22,398

 

$

569

 

 

2.5

%

Cost of Service Revenue

 

16,898

 

 

17,026

 

 

(128

)

 

(0.8

%)

Gross Profit

$

6,069

 

$

5,372

 

$

697

 

 

13.0

%

Gross Margin

 

26.4%

 

 

24.0%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

$

2,348

 

$

2,386

 

$

(38

)

 

(1.6

%)

General and Administrative Expenses

 

2,592

 

 

2,248

 

 

344

 

 

15.3

%

Operating Income

$

1,129

 

$

738

 

$

391

 

 

53.0

%

% of Revenue

 

4.9%

 

 

3.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

DISTRIBUTION

FY 2021 Q1

 

FY 2020 Q1

 

$’s

 

%

Distribution Sales

$

15,937

 

$

19,997

 

 

(4,060

)

 

(20.3

%)

Cost of Distribution Sales

 

12,597

 

 

15,317

 

 

(2,720

)

 

(17.8

%)

Gross Profit

$

3,340

 

$

4,680

 

$

(1,340

)

 

(28.6

%)

Gross Margin

 

21.0%

 

 

23.4%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

$

1,726

 

$

2,086

 

$

(360

)

 

(17.3

%)

General and Administrative Expenses

 

1,779

 

 

1,374

 

 

405

 

 

29.5

%

Operating Income

$

(165)

 

$

1,220

 

 

(1,385

)

 

(113.5

%)

% of Sales

 

(1.0%)

 

 

6.1%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change

TOTAL

FY 2021 Q1

 

FY 2020 Q1

 

$’s

 

%

 

 

 

 

 

 

 

 

Total Revenue

$

38,904

 

$

42,395

 

$

(3,491

)

 

(8.2

%)

Total Cost of Revenue

 

29,495

 

 

32,343

 

 

(2,848

)

 

(8.8

%)

Gross Profit

$

9,409

 

$

10,052

 

$

(643

)

 

(6.4

%)

Gross Margin

 

24.2%

 

 

23.7%

 

 

 

 

 

 

 

 

 

 

 

 

Selling, Marketing & Warehouse Expenses

$

4,074

 

$

4,472

 

$

(398

)

 

(8.9

%)

General and Administrative Expenses

 

4,371

 

 

3,622

 

 

749

 

 

20.7

%

Operating Income

$

964

 

$

1,958

 

$

(994

)

 

(50.8

%)

% of Revenue

 

2.5%

 

 

4.6%